BlackRock’s Kestra Medical Technologies KMTS Stock Holding History
Bought
Maintained
Sold
Other funds holding KMTS
BCI
AP
YF
EAM
BlackRock's KMTS Position: Q2 2026 in Review
BlackRock increased its Kestra Medical Technologies (KMTS) stake by 10% in Q2 2026, buying an estimated $3.69M and bringing the position to 1,865,496 shares worth $47.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2707.
BlackRock first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.
- BlackRock held 1,865,496 shares of Kestra Medical Technologies worth $47.5M as of Q2 2026.
- BlackRock bought 176,249 Kestra Medical Technologies shares in Q2 2026, an estimated $3.69M.
- Kestra Medical Technologies made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2707 holding.
- BlackRock first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
- 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.